Re-Engineering Drug Development II: Clinical Data Collection & Management

 
• By Antonio Regalado

Despite a history of failed products, start-up companies are looking to reinvent how data from clinical trials is collected and managed. Firms are trying to replace the point solutions of the past with broad software offerings that can take clients from "site to submission."

Eli Lilly & Co. Parexel International Corp. Quintiles Transnational Corp. Covance Inc. Pharmaceutical Product Development Inc.

In front-page cover age of the pharmaceutical industry's latest proposed mega-merger, a Wall Street Journalheadline trumpeted "Cost of Drug Research...

More from Archive

More from Scrip